Drug Combination Boosts Survival Rate In Head And Neck Cancers

... Adding a third drug to a standard chemotherapy combination can dramatically improve the survival of patients with advanced head and neck cancer, according to a study led by researchers at Dana-Farber. Combination chemotherapy of cisplatin and 5-fu yields a 25 to 50 percent rate of complete pathological responses (the tumor disappeared). The new study found that adding docetaxel (Taxotere) to the cisplatin and 5-fu regimen increased the complete pathological response rate to 89 percent. ...